Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1991-10-31
|
pubmed:abstractText |
A risk of beta 2-microglobulin (beta 2-M)-associated amyloidosis in long-term CAPD patients has been recognised. We examined the kinetics of beta 2-M and potential clinical manifestations of amyloidosis in patients well-established on CAPD for 1-76 months (mean +/- SEM; 16.4 +/- 14 months). In 57 patients, serum beta 2-M concentration was elevated to 30 +/- 1.8 (mean +/- SEM, mg/l) and correlated positively with the duration on CAPD. In 18 patients studied with variable degrees of residual renal function, serum beta 2-M concentration increased with declining renal function; this was most marked when the creatinine clearance was less than 1 ml/min. Using an isosmolar solution (302 +/- 1.3 mOsm/kg) containing 5% glucose polymer (9.4 mmol/l; MW 16,800), the transperitoneal elimination of beta 2-M was significantly enhanced (1.6 times) compared to conventional 1.36% glucose solution, but without a detectable change in serum concentrations during a 6-h study. No significant difference was found between the estimated minimum volume of distribution of beta 2-M in CAPD and haemodialysis patients. Symptomatic amyloid-associated disease was absent in patients in this study, and may be attributed to the short duration of dialysis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0931-0509
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
513-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2130298-Adult,
pubmed-meshheading:2130298-Aged,
pubmed-meshheading:2130298-Amyloidosis,
pubmed-meshheading:2130298-Ascitic Fluid,
pubmed-meshheading:2130298-Female,
pubmed-meshheading:2130298-Glucans,
pubmed-meshheading:2130298-Humans,
pubmed-meshheading:2130298-Kidney,
pubmed-meshheading:2130298-Kidney Transplantation,
pubmed-meshheading:2130298-Kinetics,
pubmed-meshheading:2130298-Male,
pubmed-meshheading:2130298-Metabolic Clearance Rate,
pubmed-meshheading:2130298-Middle Aged,
pubmed-meshheading:2130298-Peritoneal Dialysis, Continuous Ambulatory,
pubmed-meshheading:2130298-Ultrafiltration,
pubmed-meshheading:2130298-beta 2-Microglobulin
|
pubmed:year |
1990
|
pubmed:articleTitle |
Kinetic and clinical studies of beta 2-microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer.
|
pubmed:affiliation |
Department of Renal Medicine, Manchester Royal Infirmary, UK.
|
pubmed:publicationType |
Journal Article
|